Cargando…

LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1

Objective: Laryngeal squamous cell carcinoma (LSCC) belongs to head and neck squamous cell carcinoma (HNSCC), with dismal prognosis. Here, this study aims to disclose the role of LINC-PINT in cancer development, which may contribute to improving the clinical outcomes of LSCC treatment. Methods: LINC...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xianguang, Miao, Susheng, Mao, Xionghui, Xiu, Cheng, Sun, Ji, Pei, Rong, Jia, Shenshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262191/
https://www.ncbi.nlm.nih.gov/pubmed/34257531
http://dx.doi.org/10.3389/pore.2021.584466
_version_ 1783719142011961344
author Yang, Xianguang
Miao, Susheng
Mao, Xionghui
Xiu, Cheng
Sun, Ji
Pei, Rong
Jia, Shenshan
author_facet Yang, Xianguang
Miao, Susheng
Mao, Xionghui
Xiu, Cheng
Sun, Ji
Pei, Rong
Jia, Shenshan
author_sort Yang, Xianguang
collection PubMed
description Objective: Laryngeal squamous cell carcinoma (LSCC) belongs to head and neck squamous cell carcinoma (HNSCC), with dismal prognosis. Here, this study aims to disclose the role of LINC-PINT in cancer development, which may contribute to improving the clinical outcomes of LSCC treatment. Methods: LINC-PINT expression in LSCC tissues and in TU-177 and Hep-2 cells was quantified, and subsequently, the association between LINC-PINT and LSCC malignancies was analyzed. pcDNA3.1-LINC-PINT or pcDNA3.1-EZH2 was introduced into Hep-2 and TU-177 cells. qRT-PCR and Western blot analyses examined the levels of proteins related to the AKT/mTOR pathway and their phosphorylated proteins in Hep-2 and TU-177 cells. The viability as well as migration and invasion abilities of Hep-2 and TU-177 cells were determined. Also, the distribution of LINC-PINT in Hep-2 cells was investigated as well as the interplay between LINC-PINT and EZH2. The downstream genes that might interact with EZH2 were screened. Results: LINC-PINT expression was inhibited in LSCC tissues and in Hep-2 and TU-177 cells, whose downregulation was associated with unsatisfactory prognosis. LINC-PINT overexpression suppressed the proliferative, migratory and invasive capacities of Hep-2 and TU-177 cells. LINC-PINT, mainly expressing in nuclei, could enrich EZH2 to silence ZEB1. In Hep-2 and TU-177 cells, the inhibition of LINC-PINT or overexpression of ZEB1 could enhance cell proliferation, migration and invasion. The phosphorylated levels of proteins related to the AKT/mTOR pathway were declined in cells with LINC-PINT overexpression, and the levels of these phosphorylated proteins were increased in cells with LINC-PINT inhibition. Conclusion: LINC-PINT enriches EZH2 to silence ZEB1 and thus inhibits the proliferative, migratory, and invasive capacities of Hep-2 and TU-177 cells. In addition, LINC-PINT might exert its biological function through the AKT/mTOR pathway.
format Online
Article
Text
id pubmed-8262191
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-82621912021-07-12 LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1 Yang, Xianguang Miao, Susheng Mao, Xionghui Xiu, Cheng Sun, Ji Pei, Rong Jia, Shenshan Pathol Oncol Res Society Journal Archive Objective: Laryngeal squamous cell carcinoma (LSCC) belongs to head and neck squamous cell carcinoma (HNSCC), with dismal prognosis. Here, this study aims to disclose the role of LINC-PINT in cancer development, which may contribute to improving the clinical outcomes of LSCC treatment. Methods: LINC-PINT expression in LSCC tissues and in TU-177 and Hep-2 cells was quantified, and subsequently, the association between LINC-PINT and LSCC malignancies was analyzed. pcDNA3.1-LINC-PINT or pcDNA3.1-EZH2 was introduced into Hep-2 and TU-177 cells. qRT-PCR and Western blot analyses examined the levels of proteins related to the AKT/mTOR pathway and their phosphorylated proteins in Hep-2 and TU-177 cells. The viability as well as migration and invasion abilities of Hep-2 and TU-177 cells were determined. Also, the distribution of LINC-PINT in Hep-2 cells was investigated as well as the interplay between LINC-PINT and EZH2. The downstream genes that might interact with EZH2 were screened. Results: LINC-PINT expression was inhibited in LSCC tissues and in Hep-2 and TU-177 cells, whose downregulation was associated with unsatisfactory prognosis. LINC-PINT overexpression suppressed the proliferative, migratory and invasive capacities of Hep-2 and TU-177 cells. LINC-PINT, mainly expressing in nuclei, could enrich EZH2 to silence ZEB1. In Hep-2 and TU-177 cells, the inhibition of LINC-PINT or overexpression of ZEB1 could enhance cell proliferation, migration and invasion. The phosphorylated levels of proteins related to the AKT/mTOR pathway were declined in cells with LINC-PINT overexpression, and the levels of these phosphorylated proteins were increased in cells with LINC-PINT inhibition. Conclusion: LINC-PINT enriches EZH2 to silence ZEB1 and thus inhibits the proliferative, migratory, and invasive capacities of Hep-2 and TU-177 cells. In addition, LINC-PINT might exert its biological function through the AKT/mTOR pathway. Frontiers Media S.A. 2021-04-01 /pmc/articles/PMC8262191/ /pubmed/34257531 http://dx.doi.org/10.3389/pore.2021.584466 Text en Copyright © 2021 Yang, Miao, Mao, Xiu, Sun, Pei and Jia. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Society Journal Archive
Yang, Xianguang
Miao, Susheng
Mao, Xionghui
Xiu, Cheng
Sun, Ji
Pei, Rong
Jia, Shenshan
LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1
title LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1
title_full LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1
title_fullStr LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1
title_full_unstemmed LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1
title_short LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1
title_sort lncrna linc-pint inhibits malignant behaviors of laryngeal squamous cell carcinoma cells via inhibiting zeb1
topic Society Journal Archive
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262191/
https://www.ncbi.nlm.nih.gov/pubmed/34257531
http://dx.doi.org/10.3389/pore.2021.584466
work_keys_str_mv AT yangxianguang lncrnalincpintinhibitsmalignantbehaviorsoflaryngealsquamouscellcarcinomacellsviainhibitingzeb1
AT miaosusheng lncrnalincpintinhibitsmalignantbehaviorsoflaryngealsquamouscellcarcinomacellsviainhibitingzeb1
AT maoxionghui lncrnalincpintinhibitsmalignantbehaviorsoflaryngealsquamouscellcarcinomacellsviainhibitingzeb1
AT xiucheng lncrnalincpintinhibitsmalignantbehaviorsoflaryngealsquamouscellcarcinomacellsviainhibitingzeb1
AT sunji lncrnalincpintinhibitsmalignantbehaviorsoflaryngealsquamouscellcarcinomacellsviainhibitingzeb1
AT peirong lncrnalincpintinhibitsmalignantbehaviorsoflaryngealsquamouscellcarcinomacellsviainhibitingzeb1
AT jiashenshan lncrnalincpintinhibitsmalignantbehaviorsoflaryngealsquamouscellcarcinomacellsviainhibitingzeb1